Differential diagnosis of chorea

Current Neurology and Neuroscience Reports

Volumn 11, Issue 4, 2011, Pages 385-395

  Walker, Ruth H ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basal ganglia; Chorea; Huntington disease like; Huntington's disease; Neuroacanthocytosis

Indexed keywords

AMANTADINE; AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; CARBAMAZEPINE; CHLORPROMAZINE; COCAINE; ESTROGEN; ETIRACETAM; FLUPHENAZINE; GABAPENTIN; GLUTAMATE RECEPTOR ANTAGONIST; HALOPERIDOL; LAMOTRIGINE; LEVODOPA; LITHIUM; METHOTREXATE; METOCLOPRAMIDE; PROCHLORPERAZINE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHOREA; CHOREA-ACANTHOCYTOSIS; CLINICAL FEATURE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FAHR DISEASE; FAMILY HISTORY; FRONTOTEMPORAL DEMENTIA; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE LIKE SYNDROME; LABORATORY TEST; LESCH NYHAN SYNDROME; MCLEOD SYNDROME; MEDICAL HISTORY; METABOLIC DISORDER; NEURAL STEM CELL TRANSPLANTATION; NEUROFERRITINOPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PHENOTYPE; SPINOCEREBELLAR ATAXIA; TARDIVE DYSKINESIA; WILSON DISEASE; ANAMNESIS; GENETICS; PATHOPHYSIOLOGY; REVIEW;

CHOREA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MEDICAL HISTORY TAKING; NEUROLOGIC EXAMINATION; PHARMACEUTICAL PREPARATIONS;

EID: 80054825928     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0202-2     Document Type: Article

References (103)

1. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2007;22:127-30. (Pubitemid 46382686)
2. Rosenblatt A, Liang KY, Zhou H, et al. The association of CAG repeat length with clinical progression in Huntington disease. Neurology. 2006;66:1016-20. (Pubitemid 44044784)
3. Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A. 2004;101:3498-503. (Pubitemid 38338224)
4. Aziz NA, Jurgens CK, Landwehrmeyer GB, et al. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology. 2009;73:1280-5.
5. Holmes SE, O'Hearn E, Rosenblatt A, et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet. 2001;29:377-8. (Pubitemid 34326684)
6. Stevanin G, Fujigasaki H, Lebre AS, et al. Huntington's diseaselike phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain. 2003;126:1599-603.
7. Margolis RL, Holmes SE, Rosenblatt A, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004;56:670-4. (Pubitemid 39540747)
8. Walker RH, Jankovic J, O'Hearn E, Margolis RL. Phenotypic features of huntington disease-like 2. Mov Disord. 2003;18:1527-30.
9. Walker RH, Rasmussen A, Rudnicki D, et al. Huntington's Disease-like 2 can present as chorea-acanthocytosis. Neurology. 2003;61:1002-4. (Pubitemid 37248666)
10. Durr A: Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010, 9: 885-894. This is a nice summary of clinical and genetic features autosomal-dominant ataxias.
11. Namekawa M, Takiyama Y, Ando Y, et al. Choreiform movements in spinocerebellar ataxia type 1. J Neurol Sci. 2001;187:103-6. (Pubitemid 32611663)
12. Geschwind DH, Perlman S, Figueroa CP, et al. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60:842-50. (Pubitemid 27146492)
13. Rottnek M, Riggio S, Byne W, et al. Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? Am J Psychiatry. 2008;165:964-7.
14. Lee WW, Kim SY, Kim JY, et al. Extrapyramidal signs are a common feature of spinocerebellar ataxia type 17. Neurology. 2009;73:1708-9.
15. Le Ber I, Camuzat A, Castelnovo G, et al. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. Arch Neurol. 2003;60:1097-9. (Pubitemid 36975797)
16. Wardle M, Majounie E, Williams NM, et al. Dentatorubral pallidoluysian atrophy in South Wales. J Neurol Neurosurg Psychiatry. 2008;79:804-7. (Pubitemid 351914728)
17. Burke JR, Wingfield MS, Lewis KE, et al. The Haw River Syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. Nat Genet. 1994;7:521-4.
18. Mahajnah M, Inbar D, Steinmetz A, et al. Benign hereditary chorea: clinical, neuroimaging, and genetic findings. J Child Neurol. 2007;22:1231-4.
19. Bauer P, Kreuz FR, Burk K, et al. Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown cause. Mov Disord. 2006;21:1734-7. (Pubitemid 44742208)
20. Asmus F, Horber V, Pohlenz J, et al. A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa. Neurology. 2005;64:1952-4. (Pubitemid 40800715)
21. Krude H, Schutz B, Biebermann H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest. 2002;109:475-80. (Pubitemid 34171778)
22. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350-4. (Pubitemid 32702424)
23. Crompton DE, Chinnery PF, Bates D, et al. Spectrum of movement disorders in neuroferritinopathy. Mov Disord. 2004;20:95-9. (Pubitemid 40277514)
24. Kubota A, Hida A, Ichikawa Y, et al. A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotypephenotype correlations. Mov Disord. 2009;24:441-5.
25. Suls A, Dedeken P, Goffin K, et al. Paroxysmal exerciseinduced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain. 2008;131:1831-44. (Pubitemid 351957463)
26. Leen WG, Klepper J, Verbeek MM, et al.: Glucose transporter- 1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010, 133: 655-670. This is a recent update on this treatable disorder.
27. Geschwind DH, Loginov M, Stern JM. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet. 1999;65:764-72. (Pubitemid 30468722)
28. Oliveira JR, Spiteri E, Sobrido MJ, et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology. 2004;63:2165-7. (Pubitemid 39636274)
29. Wszolek ZK, Baba Y, Mackenzie IR, et al. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology. 2006;67:620-5. (Pubitemid 44273608)
30. Younes-Mhenni S, Thobois S, Streichenberger N, et al. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications. Rev Med Interne. 2002;23:1027-9. (Pubitemid 36019776)
31. Kovacs GG, Murrell JR, Horvath S, et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 2009;24:1843-7.
32. Gamez J, Corbera-Bellalta M, Mila M, et al. Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study. Mov Disord. 2008;23:434-8.
33. Pradat PF, Salachas F, Lacomblez L, et al. Association of chorea and motor neuron disease. Mov Disord. 2002;17:419-20. (Pubitemid 36054152)
34. Nielsen TR, Bruhn P, Nielsen JE, Hjermind LE. Behavioral variant of frontotemporal dementia mimicking Huntington's disease. Int Psychogeriatr. 2010;22:674-7.
35. Machado A, Fen CH, Mitiko DM, et al. Neurological manifestations in Wilson's disease: report of 119 cases. Mov Disord. 2006;21:2192-6.
36. Zhu D, Burke C, Leslie A, Nicholson GA. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion. Mov Disord. 2002;17:585-9. (Pubitemid 36040975)
37. Spacey SD, Szczygielski BI, Young SP, et al. Malaysian siblings with friedreich ataxia and chorea: a novel deletion in the frataxin gene. Can J Neurol Sci. 2004;31:383-6. (Pubitemid 39295459)
38. Verhagen MMM, Abdo WF, Willemsen MAAP, et al.: Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 2009, 73: 430-437. This article reports on features of this disorder in previously misdiagnosed adults.
39. Rampoldi L, Danek A,Monaco AP. Clinical features and molecular bases of neuroacanthocytosis. J Mol Med. 2002;80:475-91. (Pubitemid 34983912)
40. Storch A, Kornhass M, Schwarz J. Testing for acanthocytosis-a prospective reader-blinded study in movement disorder patients. J Neurol. 2005;252:84-90. (Pubitemid 40179023)
41. Rampoldi L, Dobson-Stone C, Rubio JP, et al. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet. 2001;28:119-20. (Pubitemid 32538051)
42. Dobson-Stone C, Velayos-Baeza A, Filippone LA, et al. Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol. 2004;56:299-302. (Pubitemid 39037928)
43. Velayos-Baeza A, Holinski-Feder E, Nietzel B, et al.: Choreaacanthocytosis genotype in Critchley's original Kentucky neuroacanthocytosis kindred. Arch Neurol. in press.
44. Mubaidin A, Roberts E, Hampshire D, et al. Karak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum. J Med Genet. 2003;40:543-6. (Pubitemid 36843080)
45. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology. 2003;23:345-50. (Pubitemid 38004869)
46. McNeill A, Pandolfo M, Kuhn J, et al. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol. 2008;60:200-5.
47. Friedman JR, Thiele EA, Wang D, et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord. 2006;21:241-5.
48. Sethi KD, Ray R, Roesel RA, et al. Adult-onset chorea and dementia with propionic acidemia. Neurology. 1989;39:1343-5. (Pubitemid 19246808)
49. Gascon GG, Ozand PT, Brismar J. Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations. Brain Dev. 1994;16(Suppl):94-103. (Pubitemid 124009022)
50. Hall DA, Ringel SP. Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy. Mov Disord. 2004;19:485-6. (Pubitemid 38559657)
51. Morrison PF, Sankar R, Shields WD. Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia. Pediatr Neurol. 2006;35:356-8. (Pubitemid 44636130)
52. Mellick G, Price L, Boyle R. Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord. 2004;19:727-9. (Pubitemid 39173036)
53. Brown RM, Head RA, Morris AA, et al. Pyruvate dehydrogenase E3 binding protein (protein X) deficiency. Dev Med Child Neurol. 2006;48:756-60. (Pubitemid 44227168)
54. Shulman LM, Lang AE, Jankovic J, et al. Case 1, 1995: psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction. Mov Disord. 1995;10:257-62.
55. Oates CE, Bosch EP, Hart MN. Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature. Eur Neurol. 1986;25:154-9. (Pubitemid 16168639)
56. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol. 2001;50:755-64. (Pubitemid 33116135)
57. Hewer E, Danek A, Schoser BG, et al. McLeod myopathy revisited- more neurogenic and less benign. Brain. 2007;130:3285-96. (Pubitemid 350209081)
58. Evidente VG, Advincula J, Esteban R, et al. Phenomenology of "Lubag" or X-linked dystonia-parkinsonism. Mov Disord. 2002;17:1271-7.
59. Factor SA, Barron KD. Mosaic pattern of gliosis in the neostratum of a North American man with craniocervical dystonia and parkinsonism. Mov Disord. 1997;12:783-9. (Pubitemid 27406280)
60. Gibb WR, Kilford L, Marsden CD. Severe generalised dystonia associated with a mosaic pattern of striatal gliosis. Mov Disord. 1992;7(3):217-23.
61. Goldenberg PC, Steiner RD, Merkens LS, et al. Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency. Neurology. 2003;60:865-8. (Pubitemid 36297376)
62. Crimi M, Galbiati S, Moroni I, et al. A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome. Neurology. 2003;60:1857-61. (Pubitemid 36737095)
63. Caer M, Viala K, Levy R, et al. Adult-onset chorea and mitochondrial cytopathy. Mov Disord. 2005;20:490-2. (Pubitemid 40779026)
64. Morimoto N, Nagano I, Deguchi K, et al. Leber hereditary optic neuropathy with chorea and dementia resembling Huntington disease. Neurology. 2004;63:2451-2. (Pubitemid 40024385)
65. Lee BC, Hwang SH, Chang GY. Hemiballismus-hemichorea in older diabetic women: a clinical syndrome with MRI correlation. Neurology. 1999;52:646-8. (Pubitemid 29075623)
66. Ahlskog JE, Nishino H, Evidente VG, et al. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord. 2001;16:890-8. (Pubitemid 36041191)
67. Shyambabu C, Sinha S, Taly AB, et al. Serum vitamin B12 deficiency and hyperhomocystinemia: a reversible cause of acute chorea, cerebellar ataxia in an adult with cerebral ischemia. J Neurol Sci. 2008;273:152-4.
68. Pacchetti C, Cristina S, Nappi G. Reversible chorea and focal dystonia in vitamin B12 deficiency. N Engl J Med. 2002;347:295. (Pubitemid 34787644)
69. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914-20. (Pubitemid 36889935)
70. Bowen J, Mitchell T, Pearce R, Quinn N. Chorea in new variant Creutzfeldt-Jacob disease. Mov Disord. 2000;15:1284-5.
71. McKee D, Talbot P. Chorea as a presenting feature of variant Creutzfeldt-Jakob disease. Mov Disord. 2003;18:837-8. (Pubitemid 36939985)
72. Passarin MG, Alessandrini F, Nicolini GG, et al. Reversible choreoathetosis as the early onset of HIV-encephalopathy. Neurol Sci. 2005;26:55-6. (Pubitemid 40723944)
73. Sporer B, Linke R, Seelos K, et al. HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT. J Neurol. 2005;252:356-8. (Pubitemid 40562170)
74. Ozben S, Erol C, Ozer F, Tiras R. Chorea as the presenting feature of neurosyphilis. Neurol India. 2009;57:347-9.
75. Font J, Cervera R, Espinosa G, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456-9. (Pubitemid 28428213)
76. Watanabe T, Onda H. Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis. Pediatr Nephrol. 2004;19:451-3. (Pubitemid 38477413)
77. Venegas FP, Sinning M, Miranda M. Primary Sjogren's syndrome presenting as a generalized chorea. Parkinsonism Relat Disord. 2005;11:193-4.
78. Ciubotaru CR, Esfahani F, Benedict RH, et al. Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome. J Clin Rheumatol. 2002;8:332-9. (Pubitemid 35453602)
79. Kumar H, Masiowski P, Jog M. Chorea in the elderly with mutation positive polycythemia vera: a case report. Can J Neurol Sci. 2009;36:370-2.
80. Pereira AC, Edwards MJ, Buttery PC, et al. Choreic syndrome and coeliac disease: a hitherto unrecognised association. Mov Disord. 2004;19:478-82. (Pubitemid 38559655)
81. Honnorat J, Cartalat-Carel S, Ricard D, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2009;80:412-6.
82. Dorban S, Gille M, Kessler R, et al. Chorea-athetosis in the anti- Hu syndrome. Rev Neurol (Paris). 2004;160:126-9.
83. Krolak-Salmon P, Androdias G, Meyronet D, et al. Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies. Eur J Neurol. 2006;13:307-8.
84. Vincent A, Bien CG: Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol 2008, 7: 1074-1075. This is a review of this recently recognized, but not uncommon, condition.
85. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl- D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36. (Pubitemid 46214241)
86. Surie S, Tijssen MA, Biervliet JD, et al. Chorea in adults following pulmonary endarterectomy. Mov Disord. 2010;25:1101-4.
87. Passarin MG, Romito S, Avesani M, et al. Late-onset choreoathetotic syndrome following heart surgery. Neurol Sci. 2010;31:95-7.
88. Suchowersky O, Muthipeedika J. A case of late-onset chorea. Nat Clin Pract Neurol. 2005;1:113-6.
89. Gironell A, de Molina RM, Sancho G, Kulisevsky J: Chorea induced by a luteinizing hormone-releasing hormone analog. J Neurol. 2008;255:1264-5.
90. Bota DA, Dafer RM. Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report. South Med J. 2009;102:1071-4.
91. Necioglu OD, Yldrmak Y, Kenangil G, et al. Intrathecal methotrexate-induced acute chorea. J Pediatr Hematol Oncol. 2009;31:57-8.
92. van der Plas AA, van Rijn MA, van Hilten JJ. Baclofen-induced chorea in complex regional pain syndrome-related dystonia. Mov Disord. 2010;25:959-60.
93. Weiner WJ, Nausieda PA, Klawans HL. Methylphenidateinduced chorea: case report and pharmacologic implications. Neurology. 1978;28:1041-4. (Pubitemid 8401537)
94. Thiriaux A, de St Martin A, Vercueil L, et al. Co-occurrence of infantile epileptic seizures and childhood paroxysmal choreoathetosis in one family: clinical, EEG, and SPECT characterization of episodic events. Mov Disord. 2002;17:98-104. (Pubitemid 36041265)
95. Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol. 2004;61:1025-9. (Pubitemid 38915943)
96. Gancher ST, Nutt JG. Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord. 1986;1:239-53.
97. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994;8:136-40. (Pubitemid 24308360)
98. Biolsi B, Cif L, Fertit HE, et al. Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus. J Neurosurg. 2008;109:130-2. (Pubitemid 351930532)
99. Kang GA, Heath S, Rothlind J, Starr PA: Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease. J Neurol Neurosurg Psychiatry 2010
100. Kaufman CB, Mink JW, Schwalb JM. Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia. J Neurosurg. 2010;112:847-50.
101. Cicchetti F, Saporta S, Hauser RA, et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A. 2009;106:12483-8.
102. Bachoud-Levi AC, Gaura V, Brugieres P, et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006;5:303-9.
103. Walker RH. Introduction: an approach to the patient with chorea. In: Walker RH, editor. The differential diagnosis of chorea. Oxford: Oxford University Press; 2010.